InvestorsHub Logo
Followers 251
Posts 15303
Boards Moderated 0
Alias Born 08/05/2009

Re: StockRocket post# 86057

Wednesday, 02/22/2017 8:28:34 PM

Wednesday, February 22, 2017 8:28:34 PM

Post# of 158781
"we dont even know if those shares are restricted or not"


.....this is true but Jim (NWAV's CFO) knows for CERTAIN. All everybody wants is for these guys to be transparent and upfront and honest. Something these OTC managed companies seem to struggle with. Let's hope Jim has enough integrity to come out and clear the air on this matter and ease everyone's mind. You know as well as I do everybody comes into these plays already leery and suspicious hoping for the best but expecting the worst. All everyone here needs is a voice of reason to ensure them there's no funny math taking place with the share structure. Let's hope he will come out and be just that smile Especially after this.....



Share structure conversations with CFO just days ago.....


StockRocketSaturday, 02/18/17 01:38:19 PM
Re: stockzoom post# 84777


Stockzoom....I had a long conv. with the CFO on this matter. All the info we discussed was public knowledge with the pr's, shareholder letter, Facebook, Twitter, etc... The business model is going to be nationwide clinics in legal medicinal cannabis states...with flagship centers in key geographic areas...all practices/clinics managed by them in full under their umbrella of Alternative Medicine Centers of America..(as seen on the doors of florida locations and ohio already). I will attach a post to this on how the dual model/strategy will be. Also, I did get a nugget I have not posted yet on the ss. Jim said they were cleaning up the shareholder list perhaps related to a FINRA request (I'm guessing do not for sure) and there are 150M issued common shares in the OS that he is looking to get cancelled/ returned to the treasury/or negotiate with current holders perhaps for restricted preferred. That would reduce the OS to 500M and reduce the float as well to 250M. Im totally premature with this post, and will have to wait two see what the company does. I know its a priority for Jim the CFO. The intuition I got there is they want to reduce the ss and uplist to attract real investors. Having said that, the windfall for current shareholders here is huge if that happens.

Here is the business model:


http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128683698



stockzoomWednesday, 02/22/17 08:51:10 AM
Re: None



Yesterday, had a long conversation with the CFO. Ver interesting things came up, here are few main points

- NO dilution needed going forward. The set up costs for alternative medicine centers are pretty low because they don't own brick and mortar places
- Growth strategy is going through umbrella centers - keep operating costs extremely small
- Focus on compound pharmacy - this is high profit margin business and gives better control on what they prescribe. This is where their R&D matters, Cannabis push is key thing here
- They are looking at reducing share count substantially - possibly with clear idea of listing to higher exchange - I asked explicitly about RS if they plan to list higher - He said no RS (That's big). Looks like retiring large number of shares will help, hence the push
- Florida is going to be the key focus in early stages
- He confirmed about the approximate revenue numbers, I was not sure 2 million /clinic looked big and wanted to hear from him
- Huge push in medical Cannabis in future, may that's why RSII partnership is key thing - exposure, partnerships etc. NWAV will have larger control on direction in medical cannabis
-Partnerships in another thing they are looking at on larger scales across the board
- Website with HIPPA compliance according to him will be done by the end of the month - That's great news. HIPPA integration is the key here - You need HIPPA compliant sector
- I also asked about medical cannabis focus going forward, the R&D and compounding pharmacy I believe is clear indication where this is heading
- New patient appointment may be integrated into the website/centers, that's big, start from March


I know lot of bioecth stuff and wanted to know their medical cannabis direction. I think R&D and compounding is the key, partnerships will drive the growth

All in all this is fantastic long and short term investment

NO DILUTION going forward
possible huge SHARE reduction in discussion
- I hope this happens, this will be next OWCP quickly

I really liked the open conversation, no pumping, nothing
Plain simple talk, no big promises. I look for hints to see if they are trying to pump, nothing of that sort. Looks like nice management

Good luck, all I feel is news is going to get better and better here going forward..


IMO

Never buy a stock based on my opinion of that stock.Form your own opinion by doing your own DD.My position on any stock I buy can change without notice.I am not a licensed broker or stock adviser and I really don't know what I'm doing.